APA (7th ed.) Citation

Xing, Z., Li, X., He, Z. N. T., Fang, X., Liang, H., Kuang, C., . . . Yang, Q. (2024). IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG.

Chicago Style (17th ed.) Citation

Xing, Zikang, Xuewen Li, Zhen Ning Tony He, Xin Fang, Heng Liang, Chunxiang Kuang, Aiying Li, and Qing Yang. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.

MLA (9th ed.) Citation

Xing, Zikang, et al. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.